Sfoglia per Autore OLIVA, STEFANIA
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients
2024-01-01 D'Agostino, Mattia; Bertuglia, Giuseppe; Rota-Scalabrini, Delia; Belotti, Angelo; Morè, Sonia; Corradini, Paolo; Oliva, Stefania; Ledda, Antonio; Grasso, Mariella; Pavone, Vincenzo; Ronconi, Sonia; Vincelli, Iolanda Donatella; Ballanti, Stelvio; Velluti, Cristina; Cellini, Claudia; Gozzetti, Alessandro; Palmas, Angelo D; Gamberi, Barbara; Mancuso, Katia; Paris, Laura; Zambello, Renato; Petrucci, Maria Teresa; Bruno, Benedetto; Musto, Pellegrino; Gay, Francesca
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
2023-01-01 Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
2022-01-01 Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials
2021-01-01 Chen Y.-T.; Valent E.T.; van Beers E.H.; Kuiper R.; Oliva S.; Haferlach T.; Chng W.-J.; van Vliet M.H.; Sonneveld P.; Larocca A.
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
2021-01-01 Oliva, Stefania; Hofste op Bruinink, Davine; Rihova, Lucie; D'Agostino, Mattia; Pantani, Lucia; Capra, Andrea; van der Holt, Bronno; Troia, Rossella; Petrucci, Maria Teresa; Villanova, Tania; Vsianska, Pavla; Jugooa, Romana; Brandt-Hagens, Claudia; Gilestro, Milena; Offidani, Massimo; Ribolla, Rossella; Galli, Monica; Hajek, Roman; Gay, Francesca; Cavo, Michele; Omedé, Paola; van der Velden, Vincent H J; Boccadoro, Mario; Sonneveld, Pieter
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
2021-01-01 Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?
2021-01-01 Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M.
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time?
2021-01-01 Mina R.; Bonello F.; Oliva S.
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma
2021-01-01 Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
2020-01-01 Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H.
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020-01-01 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate
2020-01-01 Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G.
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives
2020-01-01 Mina, Roberto; Oliva, Stefania; Boccadoro, Mario
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
2020-01-01 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2020-01-01 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
2020-01-01 Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A.
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies
2019-01-01 D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F.
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis
2019-01-01 Gambella M.; Omede P.; Spada S.; Muccio V.E.; Gilestro M.; Saraci E.; Grammatico S.; Larocca A.; Conticello C.; Bernardini A.; Gamberi B.; Troia R.; Liberati A.M.; Offidani M.; Rocci A.; Palumbo A.; Cavo M.; Sonneveld P.; Boccadoro M.; Oliva S.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients | 2024 | D'Agostino, Mattia; Bertuglia, Giuseppe; Rota-Scalabrini, Delia; Belotti, Angelo; Morè, Sonia; Corradini, Paolo; Oliva, Stefania; Ledda, Antonio; Grasso, Mariella; Pavone, Vincenzo; Ronconi, Sonia; Vincelli, Iolanda Donatella; Ballanti, Stelvio; Velluti, Cristina; Cellini, Claudia; Gozzetti, Alessandro; Palmas, Angelo D; Gamberi, Barbara; Mancuso, Katia; Paris, Laura; Zambello, Renato; Petrucci, Maria Teresa; Bruno, Benedetto; Musto, Pellegrino; Gay, Francesca | |
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial | 2023 | Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina | |
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma | 2022 | Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca | |
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials | 2021 | Chen Y.-T.; Valent E.T.; van Beers E.H.; Kuiper R.; Oliva S.; Haferlach T.; Chng W.-J.; van Vliet M.H.; Sonneveld P.; Larocca A. | |
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial | 2021 | Oliva, Stefania; Hofste op Bruinink, Davine; Rihova, Lucie; D'Agostino, Mattia; Pantani, Lucia; Capra, Andrea; van der Holt, Bronno; Troia, Rossella; Petrucci, Maria Teresa; Villanova, Tania; Vsianska, Pavla; Jugooa, Romana; Brandt-Hagens, Claudia; Gilestro, Milena; Offidani, Massimo; Ribolla, Rossella; Galli, Monica; Hajek, Roman; Gay, Francesca; Cavo, Michele; Omedé, Paola; van der Velden, Vincent H J; Boccadoro, Mario; Sonneveld, Pieter | |
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma | 2021 | Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele | |
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? | 2021 | Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M. | |
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time? | 2021 | Mina R.; Bonello F.; Oliva S. | |
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma | 2021 | Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò | |
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set | 2020 | Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H. | |
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing | 2020 | D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca | |
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate | 2020 | Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G. | |
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives | 2020 | Mina, Roberto; Oliva, Stefania; Boccadoro, Mario | |
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma | 2020 | Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A. | |
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | 2020 | Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P. | |
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents | 2020 | Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A. | |
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies | 2019 | D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F. | |
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis | 2019 | Gambella M.; Omede P.; Spada S.; Muccio V.E.; Gilestro M.; Saraci E.; Grammatico S.; Larocca A.; Conticello C.; Bernardini A.; Gamberi B.; Troia R.; Liberati A.M.; Offidani M.; Rocci A.; Palumbo A.; Cavo M.; Sonneveld P.; Boccadoro M.; Oliva S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile